This protocol is judged by an institutional evaluation board, an impartial team that testimonials any scientific trials involving people. If a review involves a Schedule I drug, once the board approves the protocol as ethical, the scientists have to apply for an investigational new drug (IND) range from the FDA.Drugs may also consist of mysterious